Metastases remain the leading cause of cancer-related mortality. The oligometastasis
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Bladder Cancer focuses on the clinical presentation and workup of suspected bladder …

Despite significant progress, metastatic urothelial cancer remains an incurable condition
with a limited life expectancy. Platinum-based chemotherapy is still the mainstay of treatment …

Simple Summary Radiotherapy with curative intent in the treatment of metastatic
malignancies has shown promising results in several types of primary tumors but experience …

Background We aimed to evaluate the prognostic value of site-specific metastases in
patients with metastatic bladder cancer and analyze the roles that surgeries play in the …

Upper tract urothelial carcinoma (UTUC) constitutes a rare and aggressive entity accounting
for 5% to 10% of all urothelial tumors. The importance of stratification and disparities …

From a clinical perspective, in de-novo omBCa, the local treatment of primary and metastatic
sites might improve disease control and survival, in selected patients; in the oligorecurrent …

Simple Summary This report presents clinically relevant advances in the management of
metastatic bladder cancer, which have been the focus of discussion of expert members of …

Background Metastatic urothelial carcinoma of the bladder, ureter, or renal pelvis is a highly
aggressive disease with poor outcomes. Even with platinum-based chemotherapy, the …

PURPOSE Urothelial cancer accounts for approximately 3% of new cancer cases
worldwide, with a high burden of disease in countries with medium and low human …